Cytokinetics, Incorporated
CYTK
$32.11
-$0.37-1.14%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 938.22M | 1.08B | 1.01B | 1.06B | 618.96M |
| Total Receivables | 2.01M | 16.65M | 244.00K | -- | 834.00K |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 15.82M | 15.28M | 6.67M | 11.04M | 18.91M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 956.05M | 1.11B | 1.02B | 1.07B | 638.70M |
|
|
|||||
| Total Current Assets | 956.05M | 1.11B | 1.02B | 1.07B | 638.70M |
| Net Property, Plant & Equipment | 144.61M | 140.97M | 140.57M | 142.94M | 146.19M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 12.70M | 7.71M | 7.73M | 7.68M | 7.81M |
| Total Assets | 1.26B | 1.40B | 1.44B | 1.52B | 808.08M |
|
|
|||||
| Total Accounts Payable | 13.94M | 20.37M | 11.58M | 9.47M | 12.97M |
| Total Accrued Expenses | 43.36M | 55.32M | 49.83M | 39.81M | 40.12M |
| Short-term Debt | 11.70M | 11.30M | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 32.53M | 30.70M | 30.38M | 30.03M | 29.75M |
| Total Finance Division Other Current Liabilities | 58.19M | 61.98M | 18.03M | 23.47M | 6.02M |
| Total Other Current Liabilities | 58.19M | 61.98M | 18.03M | 23.47M | 6.02M |
| Total Current Liabilities | 159.73M | 179.67M | 109.81M | 102.78M | 88.86M |
|
|
|||||
| Total Current Liabilities | 159.73M | 179.67M | 109.81M | 102.78M | 88.86M |
| Long-Term Debt | 764.57M | 768.60M | 763.10M | 643.43M | 606.61M |
| Short-term Debt | 11.70M | 11.30M | -- | -- | -- |
| Capital Leases | 113.35M | 112.58M | 114.75M | 116.72M | 118.56M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 492.82M | 476.19M | 462.31M | 552.31M | 390.22M |
| Total Liabilities | 1.53B | 1.54B | 1.45B | 1.42B | 1.20B |
|
|
|||||
| Common Stock & APIC | 2.60B | 2.56B | 2.53B | 2.50B | 1.85B |
| Retained Earnings | -2.86B | -2.70B | -2.55B | -2.39B | -2.25B |
| Treasury Stock & Other | 1.55M | 2.40M | 5.39M | -1.02M | -539.00K |
| Total Common Equity | -266.41M | -135.37M | -13.91M | 108.55M | -396.16M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -266.41M | -135.37M | -13.91M | 108.55M | -396.16M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -266.41M | -135.37M | -13.91M | 108.55M | -396.16M |
|
|
|||||